Lv2
178 积分 2026-05-20 加入
Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826
1个月前
已完结
Suzetrigine and the emergence of selective NaV1.8 inhibition in acute pain pharmacotherapy: efficacy, safety, and future clinical positioning
1个月前
已完结
Painful Research: Identification of a Small-Molecule Inhibitor that Selectively Targets Nav1.8 Sodium Channels
1个月前
已完结
Licochalcone Mediates the Pain Relief by Targeting the Voltage-Gated Sodium Channel
1个月前
已完结
Inhibition of TTX-S Na(+) currents by a novel blocker QLS-278 for antinociception
1个月前
已关闭
Novel drug targets in 2025
3个月前
已完结
Sodium Channels in Primary Sensory Neurons: Relationship to Pain States
4个月前
已完结
Suzetrigine: First Approval
4个月前
已完结
Comparative safety and efficacy of remimazolam versus propofol for ERCP with the patient under deep sedation: a multicenter randomized controlled trial
4个月前
已完结
Safety and efficacy of remimazolam versus propofol during EUS: a multicenter randomized controlled study
4个月前
已完结
皖公网安备34019202002308
